Immuron LimitedASX: IMC

Immuron launch PROIBS for IBS

· Issued by Immuron Limited

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Immuron Limited has announced the launch of PROIBS for treating Irritable Bowel Syndrome in Australia, with initial pharmacy orders already received. The product is designed to alleviate symptoms such as abdominal pain and bloating, and is positioned to be available online and in selected pharmacies. The Chief Commercial Officer emphasized the importance of this launch coinciding with the peak festive season when IBS symptoms are most prevalent.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Immuron Limited on 6ix

In the deck

Earlier from Immuron

Later from Immuron

All Immuron news releases